Table 1 Comparison of AIS patients receiving intravenous thrombolysis in 2020 and 2021
Characteristics | 2020 (n = 735) | 2021 (n = 1719) | U/χ2 | P value |
|---|---|---|---|---|
Sex [n (%)] | ||||
Male | 507 (69.0) | 1122 (65.3) | 3.174 | 0.075 |
Female | 228 (31.0) | 597 (34.7) | ||
Age (years, median (P25, P75) | 68 (61, 74) | 67 (59, 75) | 611,432 | 0.207 |
Mode of transportation to the hospital [n (%)] | ||||
No ambulance support | 617 (83.9) | 1394 (81.1) | 8.695 | 0.034 |
Nosocomial attacks | 2 (0.3) | 20 (1.2) | ||
"120″ ambulance services | 107 (14.6) | 293 (17) | ||
Transferred from other hospitals | 9 (1.2) | 12 (0.7) | ||
Before thrombolysis NIHSS (score, median (P25, P50)) | 5 (3, 11) | 5 (2, 10) | 598,775 | 0.040 |
ODT (min, median (P25, P75)) | 100 (60, 155) | 112 (61, 160) | 595,541 | 0.024 |
ONT (min, median (P25, P75)) | 165 (127, 225) | 160 (116, 210) | 581,733 | 0.002 |
DNT (min, median (P25, P75)) | 59 (44, 80) | 45 (32, 59) | 419,387 | < 0.001 |
Name of thrombolytic drug [n(%)] | ||||
Urokinase | 121 (16.5) | 266 (15.5) | 0.379 | 0.538 |
Alteplase | 614 (83.5) | 1453 (84.5) | ||